This is a requirement for understanding their roles in cellular transformation, because mutations detected in cancer can inactivate or impair DNA methylation (for example, DNMT3A mutations) or DNA demethylation (for example, TET2 or IDH mutations). The gene discussed is TET2; the disease is cancer.